|
|
|
Insider
Information: |
Kerins Patrick J |
Relationship: |
10% Owner |
City: |
Baltimore |
State: |
MD |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
36 |
|
Direct
Shares |
2,400,049 |
|
Indirect Shares
|
216,112,072 |
|
|
Direct
Value |
$2,847,453 |
|
|
Indirect Value
|
$648,220,632 |
|
|
Total
Shares |
218,512,121 |
|
|
Total
Value |
$651,068,085 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
3
|
Stock
price went up :
|
0
|
1
|
Stock
price went down : |
0
|
2
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
-59.5%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Hemosense Inc |
HEM |
10% Owner |
2006-12-12 |
1,772,151 |
|
0 |
Premium* |
|
Aryx Therapeutics Inc |
ARYX |
10% Owner |
|
0 |
2011-03-10 |
0 |
Premium* |
|
Echo Global Logistics Inc |
ECHO |
10% Owner |
2012-02-28 |
97 |
2012-02-28 |
0 |
Premium* |
|
Viracta Therapeutics Ord Shs |
VIRX |
10% Owner |
2010-06-30 |
0 |
2014-08-29 |
4,659,333 |
Premium* |
|
Groupon, Inc. |
GRPN |
10% Owner |
2013-09-13 |
7,944 |
2013-09-13 |
0 |
Premium* |
|
Clovis Oncology, Inc. |
CLVS |
10% Owner |
2013-06-03 |
575 |
2013-06-03 |
0 |
Premium* |
|
Millennial Media Inc |
MM |
Director |
2015-10-22 |
15,625 |
2015-10-22 |
0 |
Premium* |
|
Tesaro, Inc. |
TSRO |
10% Owner |
2019-01-22 |
0 |
2019-01-22 |
0 |
Premium* |
|
Hyperion Therapeutics Inc |
HPTX |
10% Owner |
2015-05-07 |
0 |
2015-05-07 |
0 |
Premium* |
|
Workday, Inc. |
WDAY |
10% Owner |
2013-04-10 |
1,730 |
2013-04-10 |
0 |
Premium* |
|
Interleukin Genetics Inc |
ILIU |
10% Owner |
|
0 |
2016-07-29 |
55,418,811 |
Premium* |
|
Channeladvisor Corp |
ECOM |
Director |
2016-03-01 |
35,853 |
2015-12-14 |
0 |
Premium* |
|
Epizyme, Inc. |
EPZM |
10% Owner |
2016-01-12 |
651 |
2016-01-12 |
6,260,851 |
Premium* |
|
Care.com Inc |
CRCM |
10% Owner |
2017-11-06 |
504 |
2017-11-06 |
0 |
Premium* |
|
Roka Bioscience, Inc. |
ROKA |
10% Owner |
|
0 |
2014-07-22 |
3,216,810 |
Premium* |
|
Loxo Oncology, Inc. |
LOXO |
10% Owner |
2014-08-06 |
0 |
2014-08-06 |
1,789,420 |
Premium* |
|
Ardelyx Inc |
ARDX |
10% Owner |
2020-06-10 |
11,324 |
2020-06-10 |
0 |
Premium* |
|
Box Inc |
BOX |
10% Owner |
|
0 |
2015-01-28 |
0 |
Premium* |
|
Tracon Pharmaceuticals, Inc. |
TCON |
10% Owner |
2015-02-04 |
0 |
2016-11-29 |
2,758,039 |
Premium* |
|
Champions Biotechnology Inc |
CSBR |
10% Owner |
|
0 |
2015-03-11 |
18,750,000 |
Premium* |
|
Synlogic Inc |
SYBX |
10% Owner |
2015-10-05 |
0 |
2018-01-26 |
4,228,940 |
Premium* |
|
Avalo Therapeutics, Inc |
AVTX |
10% Owner |
2015-10-20 |
0 |
2015-10-20 |
594,245 |
Premium* |
|
Adaptimmune Therapeutics PLC |
ADAP |
10% Owner |
|
0 |
2018-09-07 |
82,978,668 |
Premium* |
|
Ra Pharmaceuticals, Inc. |
RARX |
10% Owner |
2016-10-31 |
0 |
2016-10-31 |
3,490,073 |
Premium* |
|
Mulesoft, Inc |
MULE |
10% Owner |
|
0 |
2018-05-01 |
0 |
Premium* |
|
Mersana Therapeutics, Inc. |
MRSN |
10% Owner |
2020-09-14 |
3,594 |
2020-09-14 |
0 |
Premium* |
|
Surface Oncology, Inc. |
SURF |
10% Owner |
2018-04-23 |
0 |
2018-04-23 |
3,312,877 |
Premium* |
|
Rhythm Pharmaceuticals, Inc. |
RYTM |
10% Owner |
2017-10-10 |
0 |
2017-10-10 |
4,909,956 |
Premium* |
|
Appian Corp |
APPN |
10% Owner |
2018-02-13 |
1,523 |
2018-02-13 |
0 |
Premium* |
|
Liquidia Technologies Inc |
LQDA |
10% Owner |
2018-07-30 |
0 |
2018-07-30 |
2,484,870 |
Premium* |
|
Oyster Point Pharma, Inc. |
OYST |
10% Owner |
|
0 |
2019-10-30 |
5,925,287 |
Premium* |
|
Cloudflare, Inc. |
NET |
10% Owner |
2020-11-11 |
203,454 |
2020-11-11 |
0 |
Premium* |
|
Sprout Social, Inc. |
SPT |
10% Owner |
2020-11-13 |
38,644 |
2020-11-13 |
0 |
Premium* |
|
Coursera, Inc. |
COUR |
10% Owner |
2021-05-19 |
70,394 |
2021-05-19 |
0 |
Premium* |
|
BuzzFeed, Inc |
BZFD |
Director, 10% Owner |
2023-12-03 |
222,847 |
2023-12-03 |
15,333,892 |
Premium* |
|
Sagimet Biosciences Inc. |
SGMT |
10% Owner |
2024-01-29 |
13,139 |
2024-01-29 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
217 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 5 of 9
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
CRCM |
Care.com Inc |
10% Owner |
|
2017-11-06 |
4 |
D |
$0.00 |
$0 |
I/I |
(1,010,000) |
0 |
0 |
- |
|
APPN |
Appian Corp |
10% Owner |
|
2017-11-20 |
4 |
S |
$19.49 |
$54,971,857 |
I/I |
(2,820,516) |
0 |
0 |
- |
|
APPN |
Appian Corp |
10% Owner |
|
2017-11-20 |
4 |
A |
$0.00 |
$0 |
I/I |
2,820,516 |
2,820,516 |
0 |
- |
|
APPN |
Appian Corp |
10% Owner |
|
2017-11-27 |
4 |
S |
$19.49 |
$11,101,894 |
I/I |
(569,620) |
0 |
0 |
- |
|
APPN |
Appian Corp |
10% Owner |
|
2017-11-27 |
4 |
A |
$0.00 |
$0 |
I/I |
569,620 |
569,620 |
0 |
- |
|
SYBX |
Synlogic Inc |
10% Owner |
|
2018-01-26 |
4 |
A |
$9.75 |
$3,997,500 |
I/I |
410,000 |
4,228,940 |
0 |
- |
|
APPN |
Appian Corp |
10% Owner |
|
2018-02-13 |
4 |
A |
$0.00 |
$0 |
I/I |
2,724,202 |
2,724,202 |
0 |
- |
|
APPN |
Appian Corp |
10% Owner |
|
2018-02-13 |
4 |
A |
$0.00 |
$0 |
I/I |
40,863 |
13,621 |
0 |
- |
|
APPN |
Appian Corp |
10% Owner |
|
2018-02-13 |
4 |
D |
$0.00 |
$0 |
I/I |
(2,765,065) |
0 |
0 |
- |
|
APPN |
Appian Corp |
10% Owner |
|
2018-02-13 |
4 |
A |
$0.00 |
$0 |
D/D |
1,523 |
1,523 |
0 |
- |
|
TSRO |
Tesaro, Inc. |
10% Owner |
|
2018-03-02 |
4 |
B |
$54.32 |
$3,036,169 |
I/I |
54,642 |
9,619,326 |
1.5 |
- |
|
TSRO |
Tesaro, Inc. |
10% Owner |
|
2018-03-05 |
4 |
B |
$58.28 |
$2,892,600 |
I/I |
49,169 |
9,668,495 |
1.5 |
- |
|
TSRO |
Tesaro, Inc. |
10% Owner |
|
2018-03-06 |
4 |
B |
$59.82 |
$755,708 |
I/I |
12,634 |
9,681,129 |
1.5 |
- |
|
ADAP |
Adaptimmune Therapeutics ... |
10% Owner |
|
2018-03-21 |
4 |
B |
$1.81 |
$189,820 |
I/I |
104,844 |
72,243,844 |
1.5 |
- |
|
ADAP |
Adaptimmune Therapeutics ... |
10% Owner |
|
2018-03-22 |
4 |
B |
$1.90 |
$1,655,669 |
I/I |
869,574 |
73,113,418 |
1.5 |
- |
|
ADAP |
Adaptimmune Therapeutics ... |
10% Owner |
|
2018-03-23 |
4 |
B |
$1.95 |
$572,358 |
I/I |
294,090 |
73,407,508 |
1.5 |
- |
|
ADAP |
Adaptimmune Therapeutics ... |
10% Owner |
|
2018-03-26 |
4 |
B |
$1.90 |
$1,087,553 |
I/I |
571,164 |
73,978,672 |
1.5 |
- |
|
ADAP |
Adaptimmune Therapeutics ... |
10% Owner |
|
2018-03-27 |
4 |
B |
$1.92 |
$11,500,200 |
I/I |
6,000,000 |
79,978,672 |
1.5 |
- |
|
SURF |
Surface Oncology, Inc. |
10% Owner |
|
2018-04-23 |
4 |
B |
$15.00 |
$1,999,995 |
I/I |
133,333 |
3,312,877 |
1.5 |
- |
|
SURF |
Surface Oncology, Inc. |
10% Owner |
|
2018-04-23 |
4 |
A |
$0.00 |
$0 |
I/I |
3,179,544 |
3,179,544 |
0 |
- |
|
MULE |
Mulesoft, Inc |
10% Owner |
|
2018-05-01 |
4 |
A |
$0.00 |
$0 |
I/I |
12,679,970 |
12,679,970 |
0 |
- |
|
MULE |
Mulesoft, Inc |
10% Owner |
|
2018-05-01 |
4 |
D |
$0.00 |
$0 |
I/I |
(12,679,970) |
0 |
0 |
- |
|
ARDX |
Ardelyx Inc |
10% Owner |
|
2018-05-25 |
4 |
A |
$4.00 |
$1,666,668 |
I/I |
416,667 |
9,169,210 |
0 |
- |
|
LQDA |
Liquidia Technologies Inc |
10% Owner |
|
2018-07-30 |
4 |
B |
$11.00 |
$6,000,005 |
I/I |
545,455 |
2,484,870 |
1.5 |
- |
|
LQDA |
Liquidia Technologies Inc |
10% Owner |
|
2018-07-30 |
4 |
A |
$0.00 |
$0 |
I/I |
1,928,295 |
1,939,415 |
0 |
- |
|
217 Records found
|
|
Page 5 of 9 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|